Acute heart failure

Last reviewed: 27 Oct 2022
Last updated: 25 Aug 2022
25 Aug 2022

New US guidance includes updated recommendations on classification of heart failure, prevention, and treatment of symptomatic disease

A joint guideline has been released by the American Heart Association, American College of Cardiology, and Heart Failure Society of America. Revised recommendations, based on contemporary evidence and acknowledging the increasingly diverse heart failure patient populations seen in practice, include:

  • A heart failure classification that includes heart failure with mildly reduced ejection fraction (HFmrEF; ejection fraction 41%-49%) and heart failure with improved ejection fraction (HFimpEF; previous ejection fraction ≤40% improved to >40% after follow-up measurement), alongside existing categories (heart failure with reduced ejection fraction [ejection fraction ≤40%] and heart failure with preserved ejection fraction [ejection fraction ≥50%])

  • Indications for temporary and durable mechanical circulatory support (MCS) in patients with advanced heart failure

  • Post-stabilization therapy for patients with heart failure with reduced ejection fraction (ejection fraction ≤40%) now includes drugs from four medication classes, including sodium-glucose cotransporter 2 (SGLT2) inhibitors (e.g., dapagliflozin or empagliflozin) regardless of whether they have type 2 diabetes mellitus.

See Management: approach

See Etiology

See Management: treatment algorithm

Original source of update

Summary

Definition

History and exam

Key diagnostic factors

  • age >70 years
  • positive past medical history
  • dyspnea
  • pulmonary crepitations
  • peripheral edema
  • cool peripheries
  • chest pain
  • third heart sound (S3)
More key diagnostic factors

Other diagnostic factors

  • fatigue and weakness or decreased exercise tolerance
  • hypotension
  • tachycardia
  • elevated jugular venous pressure
  • displaced apex beat (point of maximal impulse)
  • dullness to percussion and decreased air entry in lung bases
  • wheezing
  • palpitations
  • cough
  • fever
  • syncope
  • murmur
  • ascites
  • hepatomegaly
  • central cyanosis
Other diagnostic factors

Risk factors

  • age >70 years
  • prior episode of heart failure
  • coronary artery disease
  • hypertension
  • valvular heart disease
  • pericardial disease
  • myocarditis
  • atrial fibrillation
  • diabetes mellitus
  • nonadherence to medications
  • excessive salt intake
  • excessive catecholamine stimulation
  • abnormal thyroid function
  • excessive alcohol intake
More risk factors

Diagnostic investigations

1st investigations to order

  • ECG
  • chest x-ray
  • Hb
  • thyroid function test
  • B-type natriuretic peptide
  • troponin
  • echocardiography
  • electrolyte panel with BUN, serum creatinine, glucose
  • lipid profile
  • liver function tests
More 1st investigations to order

Investigations to consider

  • cardiac catheterization
  • endomyocardial biopsy
  • cardiac magnetic resonance (CMR)
  • single-photon emission CT
  • positron emission tomography with or without CT
  • cardiac CT (coronary CT angiogram)
  • additional biomarkers
More investigations to consider

Treatment algorithm

ACUTE

hemodynamically stable

hypotensive (systolic BP <90 mmHg)

hypertensive crisis

ONGOING

acute episode stabilized: LVEF <50%

acute episode stabilized: LVEF ≥50%

Contributors

Authors

Syed Wamique Yusuf, MBBS, FACC, FRCPI
Syed Wamique Yusuf

Professor of Medicine

Department of Cardiology

University of Texas

MD Anderson Cancer Center

Houston

TX

Disclosures

SWY declares that he was a co-director of the American College of Cardiology (ACC) Cardiovascular Board Review Course during which he had also delivered lectures.

Acknowledgements

Dr Syed Wamique Yusuf would like to gratefully acknowledge Dr Daniel Lenihan, a previous contributor to this topic.

Disclosures

DL declares that he has no competing interests.

Peer reviewers

David Whellan, MD

Assistant Professor of Medicine

Jefferson Medical College

Philadelphia

PA

Disclosures

DW declares that he has no competing interests.

Katherine C. Wu, MD

Assistant Professor of Medicine

Johns Hopkins University School of Medicine

Baltimore

MD

Disclosures

KCW declares that she has no competing interests.

Sanjay Sharma, BSc (Hons), FRCP (UK), MD

Consultant Cardiologist

King's College Hospital London

London

UK

Disclosures

SS declares that he has no competing interests.

  • Acute heart failure images
  • Differentials

    • Pneumonia
    • Pulmonary embolism
    • Asthma
    More Differentials
  • Guidelines

    • 2022 AHA/ACC/HFSA guideline for the management of heart failure
    • Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute heart failure syndromes
    More Guidelines
  • Patient leaflets

    Atrial fibrillation

    Atrial fibrillation: what is it?

    More Patient leaflets
  • Videos

    Central venous catheter insertion: animated demonstration

    How to perform an ECG: animated demonstration

    More videos
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer